Toggle Navigation
Each
Pod
Each
Pod
Podcasts
Episodes
Genres
Login
Oncology Times - OncTimes Talk
Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma
Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma
Author
Oncology Times
Published
Fri 10 Jan 2025
Episode Link
https://traffic.libsyn.com/secure/otbroadcastsarchives/OT_POD_EP125_010825.mp3
Share to:
